DEF 14A

Company

Protalix BioTherapeutics, Inc.

Filed

July 1, 2016

Period of Report

August 7, 2016

Accession Number

0001144204-16-111273

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →